Navigation Links
Vitamin D Linked to HDL Cholesterol - Shaklee Corporation Research Links Vitamin D with Key Biomarkers for Metabolic Syndrome and Heart Disease

PLEASANTON, Calif., May 1 /PRNewswire/ -- Research supported by Shaklee Corporation, the number one natural nutrition company in the U.S., shows that a lower blood vitamin D level is associated with metabolic syndrome and other risk factors for cardiovascular disease.

The study results are currently being presented at the National Lipid Association Annual Scientific Sessions in Miami, Florida and suggest an important role of vitamin D nutrition for maintaining cardiovascular health.

Roger Barnett, Chairman and CEO of Shaklee Corporation says, "Shaklee has a 53 year heritage of conducting scientific research as science continues to be the strategic driver guiding our product development and innovation." The scientific community is advocating higher intake of vitamin D to address the suboptimal vitamin D blood levels found in many Americans. Researchers have linked low vitamin D intakes to osteoporosis or brittle bones, high blood pressure, heart disease, autoimmune diseases and certain cancers.

This cross-sectional study assessed the relationships between serum 25-hydroxyvitamin D and cardiovascular disease risk markers, including the metabolic syndrome and its components, in 257 men and women, most of whom were attending Shaklee's national conference in New Orleans in August, 2008. Total vitamin D intake and intake of vitamin D from dietary supplements were both strongly associated with serum vitamin D level. High density lipoprotein cholesterol (HDL-C or "good cholesterol") concentration increased as vitamin D intakes increased. Each 10 ng/mL increase in serum vitamin D was associated with a 4.2 mg/dL increase in HDL-C and the prevalence of metabolic syndrome decreased significantly as serum vitamin D levels increased.

"Shaklee's heritage has been about improving people's health and well-being and we are proud of supporting this important research. The findings may have significant public health implications related to new understanding about benefits related to vitamin D supplementation," says Dr. Jamie McManus M.D., Chairman of Medical Affairs, Health Sciences and Education, Shaklee Corporation. "Our next study, which is already underway, is intended to confirm causality by showing that vitamin D supplementation improves cardiovascular risk factors."

Kevin C. Maki, PhD, the study's Principal Investigator and the Chief Science Officer of Provident Clinical Research, Glen Ellyn, IL, says, "Results from population studies suggest that a low serum vitamin D concentration is an independent risk factor for cardiovascular mortality, but this is the first study to evaluate the relationship between vitamin D status and cardiovascular risk factors in a group that includes a large number of vitamin D supplement users." He continues, "Additional research is warranted to assess whether increasing vitamin D intake will improve the metabolic cardiovascular risk factor profile."

Shaklee products are available exclusively through Shaklee Independent Distributors or at

About Shaklee Corporation

Founded more than 50 years ago, Shaklee has been a leading provider of premium-quality natural nutrition products, personal care products, and environmentally friendly home care products. In 2000, Shaklee became the first company in the world to be Climate Neutral(TM) certified to totally offset its CO2 emissions, resulting in a net-zero impact on the environment. With a robust product portfolio, including over 50 patents and patents pending worldwide, Shaklee has more than 750,000 Members and Distributors worldwide and operates in the U.S., Mexico, Canada, Japan, Malaysia, Taiwan, and China. For information about Shaklee, visit

SOURCE Shaklee Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. 7 Top Rated Immune Support Products from Swanson Vitamins
2. Low vitamin D causes problems for acutely ill patients
3. Critically Ill Patients Lack Vitamin D
4. New Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
5. Type of vitamin B1 could treat common cause of blindness
6. Low Vitamin A, C Intake Tied to Asthma Risk
7. Low Vitamin E, C Intake Tied to Asthma Risk
8. Hero Nutritionals Launches its New "Vitamin D3 Formula of Slice of Life Gummy Vitamins for Adults."
9. Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery
10. Warns of Problems with Mulitivitamins and Vitamin Water
11. Enzyme and vitamin define the yin and yang of asthma
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... The print component ... Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a circulation of ... distributed nationally, through a vast social media strategy and across a network of ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group ... group of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., ... the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 ... brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive not ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Representative. As a franchise owner, Somu now offers travelers, value and care based ... packages, private cruise sales, as well as, cabin upgrades and special amenities such ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie voor ... ) --> ... ) Uit ... Centrum (LUMC) blijkt ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Japanese therapeutic drug monitoring market, including emerging ...
Breaking Medicine Technology: